Griffonia stimulates brain activity and provides 5-HTP (a precursor of serotonin)
Investigations persist into innovative delivery methods and formulations that may improve absorption, prolong duration of effect, or provide alternate routes of administration
Budgeting for the new therapy remains a huge challenge, but with emerging evidence and pricing dynamics, plan sponsors should revisit older cost-benefit analyses
Metformin treatment should not be initiated in patients 80 years of age unless measurement of creatinine clearance demonstrates that renal function is not reduced, as these patients are more susceptible to developing lactic acidosis
Navitus Health Solutions commissions regular Pulse Surveys on health-related topics important to Americans to provide useful data and insights into issues shaping healthcare access, affordability and benefit design
In June 2026 the MHRA approved the Wegovy pill (oral semaglutide 25 mg), the first oral GLP-1 medicine licensed in the UK specifically for weight management
